Watch for Leqvio, a New Med for High Cholesterol

You'll hear buzz about Leqvio (inclisiran), a new Rx injectable to lower "bad" cholesterol, or LDL.

Think of Leqvio as similar to the PCSK9 inhibitors, Praluent (alirocumab) and Repatha (evolocumab).

It'll be an option to add to a statin (atorvastatin, etc) in patients with heart disease or VERY high cholesterol that's hereditary.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote